Erlotinib Completed Phase 1 Trials for Cancer, Advanced Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00543504Bevacizumab in Multiple Phase I Combinations
NCT01287546A Study of LY2875358 in Participants With Advanced Cancer
NCT00895687Study of Erlotinib in Combination With Bortezomib
NCT00895128Study of Erlotinib in Combination With Dasatinib